The serum EFNA1 and MMP13 concentrations in patients with early-stage GC (TNM stage 0 + I + IIA) are similar to those in patients with all-stage GC, and both are significantly higher than those of normal controls (Table 2). This evidence concerns the gene MMP13 and gastric cancer.